What does the evidence say about Phosphatidylserine Cortisol Exercise Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Phosphatidylserine Cortisol Exercise Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - These reports point out that cortisol is released in response to glycogen depletion or reduced blood glucose levels to maintain the blood glucose level, delaying fatigue. [Tsuda Yuichi (2020); evidence level 2] - reported that physical conditioning is associated with a reduction in pituitary-adrenal activation in response to exercise (i.e., highly trained athletes have diminished responses of ACTH and cortisol to CRH) []. [Tsuda Yuichi (2020); evidence level 2] - This indicates that the increase in mitochondrial capacity by training shifts fuels to more fat burning and glycogen sparing, thus preventing reduced blood glucose levels, which can contribute to a reduction in the pituitary-adrenal response. [Tsuda Yuichi (2020); evidence level 2] - 1 2 3 6 7 8 9 10 11 12 15 16 17 Stress causes activation of the hypothalamic-pituitary-adrenal (HPA) axis [,]. [Tsuda Yuichi (2020); evidence level 2] - Results Mean peak cortisol concentrations and area under the curve (AUC) were lower following PS (39 +/- 1% and 35 +/- 0%, respectively) when compared to placebo (p Conclusion The findings suggest that PS is an effective supplement for combating exercise-induced stress and preventing the physiological deterioration that can accompany too much exercise. [Starks MA (2008); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.